Article thumbnail

Postmenopausal hormone therapy and mammographic breast density

By Diego Marchesoni, Lorenza Driul, A Ianni, G Fabiani, M Della Martina, C Zuiani and M BAzzocchi


The aim of this study was to evaluate the effects of different types of hormone replacement therapy (HRT) on mammographic density.In a prospective 1-year study, 103 postmenopausal women were randomized to receive tibolone 2.5 mg/die, continuous conjugated equine estrogens 0.625 mg/die plus medroxyprogesterone acetate (MPA) 5mg/die or placebo. Mammograms were performed at baseline and after 12 months of treatment. Mammographic density was quantified according to the Wolfe classification.After 12 months of HRT 16 of the 35 patients (45.1%) receiving continuous combined hormonal therapy showed an increase of breast density change in the Wolfe classification. After treatment with tibolone, an up grading in breast density, according to Wolfe's classification, was found in 2 of the 43 patients (2.3%). No changes were recorded in the 25 patients of the control group. The difference between the group treated with continuous combined hormonal therapy and the control group was highly significant (p<0.001). The difference in breast density between patients in treatment with tibolone and the control group was not statistically significant (p=0.34).Continuous combination HRT may be more commonly associated with an increase of mammography density than tibolone treatment

Publisher: 'Elsevier BV'
Year: 2006
DOI identifier: 10.1016/j.maturitas.2005.02.010
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.